|
|
Post by lazyb767 on Jul 2, 2021 11:32:52 GMT -5
Top Picks Mid-Year Updates- MannKind“Though it is smaller than it was at its peak, there is still a sizable short interest in the stock, and I believe this "built-in buy order" will help move the stock higher as folks stuck on that side of the trade continue to close out their positions as time goes by. MNKD remains a very strong buy under $5 and a buy under $10.”
|
|
|
|
Post by itellthefuture777 on Jul 2, 2021 11:39:00 GMT -5
Top Picks Mid-Year Updates- MannKind“ Though it is smaller than it was at its peak, there is still a sizable short interest in the stock, and I believe this "built-in buy order" will help move the stock higher as folks stuck on that side of the trade continue to close out their positions as time goes by. MNKD remains a very strong buy under $5 and a buy under $10.” Actually anything under $6 presplit post split..$30....This stock shouldn't be under $300 a share..imo |
|
|
|
Post by sportsrancho on Jul 2, 2021 12:19:24 GMT -5
Top Picks Mid-Year Updates- MannKind“ Though it is smaller than it was at its peak, there is still a sizable short interest in the stock, and I believe this "built-in buy order" will help move the stock higher as folks stuck on that side of the trade continue to close out their positions as time goes by. MNKD remains a very strong buy under $5 and a buy under $10.” Actually anything under $6 presplit post split..$30....This stock shouldn't be under $300 a share..imo Yeah amazing how these reverse splits aren’t supposed to matter but yet they do. |
|
|
|
Post by awesomo on Jul 2, 2021 12:43:29 GMT -5
Actually anything under $6 presplit post split..$30....This stock shouldn't be under $300 a share..imo Yeah amazing how these reverse splits aren’t supposed to matter but yet they do. It's a huge target on a company that reeks of desperation and says "SHORT US". If you have to resort to artificially propping up the share price for whatever reason (delisting, etc), you are not in a good place. |
|
|
|
Post by dh4mizzou on Jul 2, 2021 13:06:30 GMT -5
Top Picks Mid-Year Updates- MannKind“ Though it is smaller than it was at its peak, there is still a sizable short interest in the stock, and I believe this "built-in buy order" will help move the stock higher as folks stuck on that side of the trade continue to close out their positions as time goes by. MNKD remains a very strong buy under $5 and a buy under $10.” Actually anything under $6 presplit post split..$30....This stock shouldn't be under $300 a share..imo itell, Will you forgive me if I sell at $ 100  |
|
|
|
Post by lakon on Jul 2, 2021 23:19:10 GMT -5
Yeah amazing how these reverse splits aren’t supposed to matter but yet they do. It's a huge target on a company that reeks of desperation and says "SHORT US". If you have to resort to artificially propping up the share price for whatever reason (delisting, etc), you are not in a good place. Psychology matters. Perception matters. Reality matters.
They all have different time horizons.
What's your percent ownership in the company? Did it go up or down? Did you buy or sell? Were you diluted or not? That's reality.
The company is not making enough money. That's reality.
Will it make a lot of money someday? That's unknown, but it depends on your perception of the situation whether or not you think so, which affects your investment decisions.
How do you handle the fear of being wrong? That's psychology affecting perception affecting reality.
I know what I own. I am not a fan of management, but I am realistic about the cards they were dealt. The bigger issues are systemic, and unfortunately I do not see them getting better for too long without intervention. Al recognized the problem and said as much. Essentially there is a bias baked into the bureaucracy against risk because making a mistake can end a career. I mean you cannot get fired from the government, but you can get sidelined forever. Therefore, bureaucrats (regulators) become extremely risk averse and incapable of making decisions when taking risks. It is much easier to just say no. Taking risks is how we learn, and unfortunately some will get Darwin Awards. That's Life. There is no way to get out alive. Yet, we are risking all progress by letting bureaucrats decide what's best for us, and some of them are well-intentioned albeit misguided. Educate yourself and make your own decisions. That's what freedom is all about. Yet, we are not free to do so anymore in many cases. Even our doctors are not free to do so. They might get sued for taking a risk, or at least have to waste their time battling with insurance companies. Again, it's systemic, and you reap what you sow. Approval got us beyond the FDA, but it was a long hard road out of the gate. Yet, the regulations still bind us. Next, we must overcome the objections of the doctors -- yet another gatekeeper. Then, the insurers and so forth. It never ends. To survive as a company or PWD, you must persevere and be patient. Finally, time will bear out the truth.
If Tyvaso DPI is approved by the FDA, I suspect this second approval of a Technosphere based DPI will ease up concerns and the perception of risk for regulators and doctors alike. A few more approvals in the pipeline should do wonders to relieve us of many systemic burdens. To me, the biggest benefit to the partnership with UTHR is the regulatory relationship, and I would love to see additional developments in partnership with UTHR.
|
|
|
|
Post by mytakeonit on Jul 3, 2021 0:24:48 GMT -5
It's a huge target on a company that reeks of desperation and says "SHORT US". If you have to resort to artificially propping up the share price for whatever reason (delisting, etc), you are not in a good place. Psychology matters. Perception matters. Reality matters.
They all have different time horizons.
What's your percent ownership in the company? Did it go up or down? Did you buy or sell? Were you diluted or not? That's reality.
The company is not making enough money. That's reality.
Will it make a lot of money someday? That's unknown, but it depends on your perception of the situation whether or not you think so, which affects your investment decisions.
How do you handle the fear of being wrong? That's psychology affecting perception affecting reality.
I know what I own. I am not a fan of management, but I am realistic about the cards they were dealt. The bigger issues are systemic, and unfortunately I do not see them getting better for too long without intervention. Al recognized the problem and said as much. Essentially there is a bias baked into the bureaucracy against risk because making a mistake can end a career. I mean you cannot get fired from the government, but you can get sidelined forever. Therefore, bureaucrats (regulators) become extremely risk averse and incapable of making decisions when taking risks. It is much easier to just say no. Taking risks is how we learn, and unfortunately some will get Darwin Awards. That's Life. There is no way to get out alive. Yet, we are risking all progress by letting bureaucrats decide what's best for us, and some of them are well-intentioned albeit misguided. Educate yourself and make your own decisions. That's what freedom is all about. Yet, we are not free to do so anymore in many cases. Even our doctors are not free to do so. They might get sued for taking a risk, or at least have to waste their time battling with insurance companies. Again, it's systemic, and you reap what you sow. Approval got us beyond the FDA, but it was a long hard road out of the gate. Yet, the regulations still bind us. Next, we must overcome the objections of the doctors -- yet another gatekeeper. Then, the insurers and so forth. It never ends. To survive as a company or PWD, you must persevere and be patient. Finally, time will bear out the truth.
If Tyvaso DPI is approved by the FDA, I suspect this second approval of a Technosphere based DPI will ease up concerns and the perception of risk for regulators and doctors alike. A few more approvals in the pipeline should do wonders to relieve us of many systemic burdens. To me, the biggest benefit to the partnership with UTHR is the regulatory relationship, and I would love to see additional developments in partnership with UTHR.
|
|
|
|
Post by mytakeonit on Jul 3, 2021 0:26:40 GMT -5
Oooh lakon ... your post puts you right on the edge of being a short. Good luck to you.
But, that's mytakeonit
|
|
|
|
Post by itellthefuture777 on Jul 3, 2021 2:47:09 GMT -5
Actually anything under $6 presplit post split..$30....This stock shouldn't be under $300 a share..imo itell, Will you forgive me if I sell at $ 100 Only if you're going to use it to buy more 😊 |
|
